Delivering the future of nucleic acid therapeutics.
Acuitas is unique. We aren’t trying to get our own drugs to market. Our full commitment is to our partners and accelerating their path to the clinic and the market, enabled by our globally validated, best-in-class lipid nanoparticle (LNP) delivery systems.
Discover the Acuitas AdvantageLatest news
View All News
Partnerships
We work with our partners to advance human health.
At Acuitas, we operate on a strategic partnership model supported by collaboration, connection and a dedication to partner success. Our established scientific and business expertise is designed to drive innovation and accelerate the development and success of our partners’ drug candidates from concept through to clinical trials, regulatory compliance and manufacturing to the marketplace.
Key Facts
1 Billion
Acuitas’ LNP delivery technology has been validated billions of times over.
180
Our LNP delivery system is used in applications in more than 180 countries.
135+
Acuitas’ scientists are published in more than 135 articles in peer-reviewed journals.
1000+
Novel cationic lipids synthesized for use in drug development.
Technology
We are the global leader in LNP delivery technology.
Acuitas specializes in the development of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics. Our LNP delivery platform is unmatched, providing enhanced safety and efficacy profiles for nucleic acid payloads, creating the opportunity to improve human health in new and innovative ways.
Acuitas’ LNP technology is the result of more than four decades of research and development and has been clinically validated billions of times over. We’ve formulated LNP platforms with exceptional stability that enable the payload to be safely delivered. In collaboration with our partners, we achieve incredible efficacy in the delivery of life-saving nucleic acid therapeutics.
Acuitas’ LNP technology is a game changer.
Nucleic acid therapeutics have exceptional potential to address a wide variety of traditionally challenging diseases such as cancer, infectious diseases, malaria, genetic illnesses and more, but they need a safe and effective delivery platform. Acuitas’ LNP is used across a broad range of applications, and through ongoing research and development, we continue to discover new and innovative clinical applications of our technology.
The Story of Acuitas
Who We Are
Inspired by science. Driven by purpose.
Acuitas Therapeutics is on a mission to advance human health and to help people around the world to lead healthier lives. Our award-winning, experienced team works together at the cutting edge of science.
There’s no better place to work than here.
At Acuitas, we collectively aim to effectively innovate to improve human health – an ambitious goal that requires a culture of mutual respect, accountability and trust. We believe that excellence and innovation are achieved through a positive, caring community of inspired individuals. The work is meaningful, and we work alongside brilliant minds and talented people who want to make a lasting impact on the world through groundbreaking developments in nucleic acid therapeutics.